| 1. | | No longer recruiting | CCI-779 in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma |
| 2. | | Recruiting | Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer
Conditions: stage IIIB breast cancer; inflammatory breast cancer |
| 3. | | Completed | Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer
Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer |
| 4. | | No longer recruiting | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
Conditions: Bone Cancer; Soft Tissue Sarcoma |
| 5. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 6. | | Recruiting | Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer |
| 7. | | Recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer
Conditions: extragonadal germ cell tumor; ovarian germ cell tumor; Testicular Cancer |
| 8. | | No longer recruiting | Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
Conditions: stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; stage II breast cancer |
| 9. | | Recruiting | Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 10. | | Recruiting | Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
Condition: Breast Cancer |
| 11. | | Completed | Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor
Condition: unspecified adult solid tumor, protocol specific |
| 12. | | No longer recruiting | Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
Conditions: Lung Cancer; lip and oral cavity cancer; Head and Neck Cancer; ovarian sarcoma; ovarian epithelial cancer; Oropharyngeal Cancer; Breast Cancer |
| 13. | | Recruiting | Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; Male Breast Cancer; recurrent breast cancer |
| 14. | | Recruiting | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
Conditions: Breast Cancer; Gastrointestinal Cancer; Kidney Cancer; Musculoskeletal Cancer; Reproductive Cancer; Skin Cancer |
| 15. | | Recruiting | Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
Condition: recurrent tumors of the Ewing's family |
| 16. | | No longer recruiting | Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; liver metastases |
| 17. | | Completed | Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 18. | | Completed | Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction
Condition: unspecified adult solid tumor, protocol specific |
| 19. | | Completed | Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor
Condition: unspecified adult solid tumor, protocol specific |
| 20. | | No longer recruiting | Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer
Condition: recurrent breast cancer |
| 21. | | No longer recruiting | R115777 in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 22. | | Completed | SU5416 and Interferon alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 23. | | Completed | SU5416 and Paclitaxel in Treating Patients With Advanced Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 24. | | No longer recruiting | Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 25. | | No longer recruiting | Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
Conditions: stage IV prostate cancer; recurrent prostate cancer |
| 26. | | No longer recruiting | UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
